Empirical Comparative Study of Variation Blood Level Antibody Vitamin D at Scleroderma (SSc) Patients Compared Healthy Peoples

Not Applicable

• Conditions: Scleroderma
• Interventions: Other: Blood sample

• Registration Number: NCT01553890
• Lead Sponsor: Meir Medical Center

Brief Summary

The aim is to find the presence of anti vitamin D antibodies in scleroderma patients and compare with control. A second goal is anti vitamin D levels in serum of scleroderma patients in relation to the clinical manifestations of the disease.

Detailed Description

Blood samples from 30 scleroderma patients compared to 30 healthy peoples to reach the target of variation of the blood level vitamin D antibody between this groups

Study Timeline

• Status Verified: 2012-01
• Study Start: 2012-03
• Study First Submitted: 2012-03-05
• Study First Submitted QC: 2012-03-13
• Last Update Submitted: 2012-03-13
• Study First Posted: 2012-03-14
• Last Update Posted: 2012-03-14
• Primary Completion: 2012-11
• Study Completion: 2013-03

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

study group

1. patients with SSc
2. age - 18 years old and older
3. sign ICF control group - healthy people

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Patients diagnosed with scleroderma	Blood sample	patients diagnosed with scleroderma, clinical and lab support
No disease	Blood sample	Blood sample, venous blood, about 10 ml will be drawn from participants

Primary Outcome Measures

Name	Time	Method
Presence of anti vitamin D antibodies in scleroderma patients compared with control	March 2013 (up to one year)

Secondary Outcome Measures

Name	Time	Method
Anti vitamin D presence and levels in serum in relation to the clinical manifestations of scleroderma	March 2013 (up to one year)